Related references
Note: Only part of the references are listed.Uncoupled Cardiac Nitric Oxide Synthase Mediates Diastolic Dysfunction
Gad A. Silberman et al.
CIRCULATION (2010)
Relation of Disease Pathogenesis and Risk Factors to Heart Failure With Preserved or Reduced Ejection Fraction Insights From the Framingham Heart Study of the National Heart, Lung, and Blood Institute
Douglas S. Lee et al.
CIRCULATION (2009)
Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study
Lars Lind et al.
EUROPEAN HEART JOURNAL (2009)
Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover
Ramon Martos et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
Sherif F. Nagueh et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2009)
Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism
Mareike Lankeit et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Prevention of heart failure - A scientific statement from the American Heart Association councils on epidemiology and prevention, clinical cardiology, cardiovascular nursing, and high blood pressure research; Quality of care and outcomes research interdisciplinary working group; and functional genomics and translational biology interdisciplinary working group
Douglas D. Schocken et al.
CIRCULATION (2008)
Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain
Kai M. Eggers et al.
EUROPEAN HEART JOURNAL (2008)
State of the art: Using natriuretic peptide levels in clinical practice
Alan Maisel et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Six minute walk test: a simple and useful test to evaluate functional capacity in patients with heart failure
Carlo Rostagno et al.
INTERNAL AND EMERGENCY MEDICINE (2008)
Biomarkers in heart failure
Eugene Braunwald
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction.
Barry M. Massie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non-ST-elevation acute coronary syndrome
Kai C. Wollert et al.
CIRCULATION (2007)
How to diagnose diastolic heart failure:: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology
Walter J. Paulus et al.
EUROPEAN HEART JOURNAL (2007)
Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure
Tibor Kempf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Cardiac myocyte gene expression profiling during H2O2-induced apoptosis
Angela Clerk et al.
PHYSIOLOGICAL GENOMICS (2007)
Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome
Kai C. Wollert et al.
CIRCULATION (2007)
Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis - A potential marker of erosive joint destruction
David A. Brown et al.
ARTHRITIS AND RHEUMATISM (2007)
Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay
Tibor Kempf et al.
CLINICAL CHEMISTRY (2007)
Trends in prevalence and outcome of heart failure with preserved ejection fraction
Theophilus E. Owan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer
Asne R. Bauskin et al.
CANCER RESEARCH (2006)
Myocardial stiffness is an important determinant of the plasma brain natriuretic peptide concentration in patients with both diastolic and systolic heart failure
S Watanabe et al.
EUROPEAN HEART JOURNAL (2006)
The transforming growth factor-β superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury
T Kempf et al.
CIRCULATION RESEARCH (2006)
GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation
J Xu et al.
CIRCULATION RESEARCH (2006)
Recommendations for chamber quantification: A report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology
RM Lang et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2005)
The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction:: correlation with echocardiographic and invasive measurements
C Tschöpe et al.
EUROPEAN HEART JOURNAL (2005)
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction:: the CHARM-Preserved Trial
S Yusuf et al.
LANCET (2003)
Share Paper
